← FDA Drug Approvals (Drugs@FDA)

NIPRIDE RTU IN SODIUM CHLORIDE 0.9%

NDA · New Drug Application · Sponsor: EXELA PHARMA · Approved 2017-03-08

Drug application

FDA Application #

NDA209387

Application type

New Drug Application

Brand name

NIPRIDE RTU IN SODIUM CHLORIDE 0.9%

Generic name

SODIUM NITROPRUSSIDE

Active ingredients

SODIUM NITROPRUSSIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EXELA PHARMA

Manufacturer

EXELA PHARMA SCIENCES, LLC

First approval

2017-03-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown